Incanthera
Goal Group
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
    • Our history
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • Investment Case
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
    • Financial calendar
    • Shareholder information
    • Investor and Advisor contacts
    • AQSE Rule 71
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us
Share price INC 17.50 GBp
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
      • Our team
      • Advisors and Founders
    • Our history
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • Investment Case
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
      • Share price chart
      • Detailed share price
    • Financial calendar
    • Shareholder information
      • Shareholder Information
      • AGM
      • Shareholder analysis
      • Analyst coverage
    • Investor and Advisor contacts
    • AQSE Rule 71
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us

Latest from Incanthera

  • Home
  • News & media
  • News
  • Press Coverage
  • Scientific Publications

Latest from Incanthera

Latest from Incanthera

  • 2021
  • 2020
  • 2018
  • Archive
August 20th, 2014 ICT01 – patent granted in Japan
June 23rd, 2014 Company starts preclinical development of ICT03-Es5 agent
May 15th, 2014 Company secures IP protection in Japan for ICT01
April 20th, 2014 Company appoints new Chiarman
April 10th, 2014 ICT01 US Patent Granted
March 18th, 2014 Incanthera acquires Onco-NX Ltd
  • Prev
  • 1
  • 2
  • 3
  • Next
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
Sign up for email alerts Register your email

This website uses cookies. By continuing to access the site you are agreeing to their use. Learn more about cookies.

  • © 2021 Incanthera plc

  • Sitemap
  • Contact Us
  • Privacy Policy

By  emperor